Anavex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.
CEOChristopher U. Missling
CEOChristopher U. Missling
Employees42
Employees42
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2004
Founded2004
Employees42
Employees42
AVXL Key Statistics
Market cap695.78M
Market cap695.78M
Price-Earnings ratio-14.70
Price-Earnings ratio-14.70
Dividend yield—
Dividend yield—
Average volume853.68K
Average volume853.68K
High today$8.56
High today$8.56
Low today$8.03
Low today$8.03
Open price$8.25
Open price$8.25
Volume894.43K
Volume894.43K
52 Week high$14.44
52 Week high$14.44
52 Week low$3.51
52 Week low$3.51
AVXL News
TipRanks 18h
Anavex Life Sciences: Strategic Opportunities and Financial Stability Drive Buy RatingRam Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on Anavex Life Sciences (AVXL – Research Report). The associated price target remains...
TipRanks 1d
Anavex Life Sciences Reports Q2 2025 Financial ResultsAnavex Life Sciences ( (AVXL) ) has released its Q2 earnings. Here is a breakdown of the information Anavex Life Sciences presented to its investors. Protect Y...
People also own
Based on the portfolios of people who own AVXL. This list is generated using Robinhood data, and it’s not a recommendation.